Pralsetinib in patients with RET fusion-positive non-small-cell lung cancer: A plain language summary of the ARROW study

  1. Griesinger, F.
  2. Curigliano, G.
  3. Subbiah, V.
  4. Baik, C.S.
  5. Tan, D.S.
  6. Lee, D.H.
  7. Misch, D.
  8. Garralda, E.
  9. Kim, D.-W.
  10. van der Wekken, A.J.
  11. Gainor, J.F.
  12. Paz-Ares, L.
  13. Liu, S.V.
  14. Kalemkerian, G.P.
  15. Bowles, D.W.
  16. Mansfield, A.S.
  17. Lin, J.J.
  18. Smoljanovic, V.
  19. Rahman, A.
  20. Zalutskaya, A.
  21. Louie-Gao, M.
  22. Boral, A.L.
  23. Mazières, J.
Journal:
Future oncology (London, England)

ISSN: 1744-8301

Year of publication: 2024

Volume: 20

Issue: 6

Pages: 297-306

Type: Review

DOI: 10.2217/FON-2023-0155 GOOGLE SCHOLAR lock_openOpen access editor